1.Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy
Licong Liang ; Yuchan Liang ; Wensou Huang ; Yongjian Guo ; Jingjun Huang ; Jingwen Zhou ; Liteng Lin ; Xinxin Nie ; Mingyue Cai ; Kangshun Zhu
Liver Research 2026;10(1):61-70
Yttrium-90 microsphere selective internal radiation therapy (SIRT), also known as transarterial radioembolization, has become one of the pivotal treatments for liver cancer, particularly for selected advantageous patient groups. This review summarizes the characteristics of different patients with liver cancer that could obtain maximum benefit from SIRT and discusses key factors affecting efficacy and safety, including tumor characteristics, liver function, patient performance status, and treatment intent. In evaluating appropriate candidates, mapping serves as a crucial simulation procedure to assess tumor vascular anatomy, predict lung shunting, and guide catheter positioning and dose planning. This procedure substantially enhances therapeutic precision while minimizing the risk of nontarget radiation-related adverse events, such as radiation-induced pneumonitis and gastrointestinal toxicity. Several studies have suggested that SIRT is not only suitable for patients with early or limited hepatocellular carcinoma but can also be used as a bridging therapy for liver transplantation and conversion therapy for unresectable liver cancers. In combination with systemic treatments, SIRT has demonstrated survival benefits in patients with unresectable liver cancer. This review also highlights the importance of further optimizing patient screening through personalized dosimetry and mapping to ensure the precision and safety of treatment. A thorough review of relevant literature and clinical practice offers clinicians comprehensive suggestions on patient screening and clarifies the promise of SIRT in the liver cancer population.
2.Autophagy Abnormalities in PCOS and Targeted Treatment with Traditional Chinese Medicine: A Review
Xinxin YANG ; Zhicheng JIA ; Mengyu SHI ; Yongqian LI ; Peixuan WANG ; Ying GUO
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(3):313-322
Polycystic ovary syndrome (PCOS) is a common gynecological endocrine and reproductive disorder,with the main clinical manifestations including ovulation failure,insulin resistance,hyperandrogenism,and obesity. Its occurrence and development are closely related to cellular regulatory mechanisms such as apoptosis,autophagy,oxidative stress,and inflammatory response. Autophagy,as a clearance mechanism that maintains cellular homeostasis,plays a crucial role in maintaining the growth,development,and maturation of oocytes. Exploring the mechanism of autophagy during the occurrence and development of diseases can help develop treatment methods for PCOS by regulating autophagy. Studies have shown that autophagy plays an important role in the pathogenesis of PCOS,and it can affect the occurrence and development of PCOS through multiple pathways,levels,and targets. Traditional Chinese medicine (TCM) regulates autophagy in ovarian granulosa cells or endometrium of patients with PCOS by targeting the expression of autophagy signaling pathways,regulatory factors,and non-coding single-stranded RNA molecules,thereby alleviating inflammation,regulating metabolism disorders,and balancing hormone levels in PCOS. Accordingly,TCM can ameliorate pathological conditions such as insulin resistance,hyperandrogenism,and ovulation failure in PCOS. This article summarizes the TCM formulas and extracts for the treatment of PCOS,as well as the main autophagy pathways and regulatory factors involved,aiming to provide reference and suggestions for the future treatment of PCOS with TCM by regulating autophagy.
3.Effect of Modified Wenyang Sanjie Prescription on Th1/Th2 Balance and Tumor Microangiogenesis in Lung Cancer Tumor-bearing Mice
Xinxin WANG ; Junhui GUO ; Honglin LI
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(17):127-134
ObjectiveTo study the tumor inhibition and T helper cell (Th)1/Th2 balance regulation effect of modified Wenyang Sanjie prescription on lung cancer tumor-bearing mice and to elaborate its mechanism. MethodsA mouse model bearing a lung cancer tumor was established by subcutaneous injection of Lewis lung cancer cells into the armpit and was randomly divided into lung cancer model group, low-dose, medium-dose, and high-dose groups of modified Wenyang Sanjie prescription, and positive control group, with 12 mice per group. The low-dose, medium-dose, and high-dose groups of modified Wenyang Sanjie prescription were given modified Wenyang Sanjie prescription by dosing at 2.5, 5, 10 g·kg-1, once a day, respectively. The positive control group was intraperitoneally injected with cisplatin (2 mg·kg-1), once every other day, for a total of 30 days. Serum interferon (IFN)-γ, interleukin (IL)-2, IL-4, IL-6, and IL-10 were determined by enzyme-linked immunosorbent assay (ELISA), and spleen index, thymus index, and tumor growth inhibition rate were calculated. Tumor microvascular density was determined by immunohistochemistry, and tumor hypoxia inducible-factor (HIF)-1α, epidermal growth factor receptor (EGFR), and vascular endothelial growth factor (VEGF) mRNA were determined by Real-time quantitative polymerase chain reaction (PCR). The protein levels of HIF-1α, EGFR, and VEGF were determined by Western blot. ResultsCompared with lung cancer model group, IFN-γ and IL-2 were increased in the modified Wenyang Sanjie prescription groups and positive control group, while IL-4, IL-6, IL-10, spleen index, thymus index, tumor weight, and tumor microvascular density were decreased, as well as HIF-1α, EGFR, and VEGF mRNA and protein levels (P<0.05). Compared to the low-dose group of modified Wenyang Sanjie prescription, IFN-γ and IL-2 were increased in the medium-dose and high-dose groups of modified Wenyang Sanjie prescription, while IL-4, IL-6, IL-10, spleen index, thymus index, tumor weight, and tumor microvascular density were decreased, as well as HIF-1α, EGFR, and VEGF mRNA and protein levels (P<0.05). IFN-γ and IL-2 were increased in the high-dose group of modified Wenyang Sanjie prescription compared to the medium-dose group of modified Wenyang Sanjie prescription, and IL-4, IL-6, IL-10, spleen index, thymus index, tumor weight, and tumor microvascular density were decreased, as well as HIF-1α, EGFR, and VEGF mRNA and protein levels (P<0.05). ConclusionModified Wenyang Sanjie prescription can significantly inhibit microangiogenesis, regulate Th1/Th2 balance, inhibit tumor growth, and significantly inhibit the progression of lung cancer in mice.
4.Effect of Modified Wenyang Sanjie Prescription on Th1/Th2 Balance and Tumor Microangiogenesis in Lung Cancer Tumor-bearing Mice
Xinxin WANG ; Junhui GUO ; Honglin LI
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(17):127-134
ObjectiveTo study the tumor inhibition and T helper cell (Th)1/Th2 balance regulation effect of modified Wenyang Sanjie prescription on lung cancer tumor-bearing mice and to elaborate its mechanism. MethodsA mouse model bearing a lung cancer tumor was established by subcutaneous injection of Lewis lung cancer cells into the armpit and was randomly divided into lung cancer model group, low-dose, medium-dose, and high-dose groups of modified Wenyang Sanjie prescription, and positive control group, with 12 mice per group. The low-dose, medium-dose, and high-dose groups of modified Wenyang Sanjie prescription were given modified Wenyang Sanjie prescription by dosing at 2.5, 5, 10 g·kg-1, once a day, respectively. The positive control group was intraperitoneally injected with cisplatin (2 mg·kg-1), once every other day, for a total of 30 days. Serum interferon (IFN)-γ, interleukin (IL)-2, IL-4, IL-6, and IL-10 were determined by enzyme-linked immunosorbent assay (ELISA), and spleen index, thymus index, and tumor growth inhibition rate were calculated. Tumor microvascular density was determined by immunohistochemistry, and tumor hypoxia inducible-factor (HIF)-1α, epidermal growth factor receptor (EGFR), and vascular endothelial growth factor (VEGF) mRNA were determined by Real-time quantitative polymerase chain reaction (PCR). The protein levels of HIF-1α, EGFR, and VEGF were determined by Western blot. ResultsCompared with lung cancer model group, IFN-γ and IL-2 were increased in the modified Wenyang Sanjie prescription groups and positive control group, while IL-4, IL-6, IL-10, spleen index, thymus index, tumor weight, and tumor microvascular density were decreased, as well as HIF-1α, EGFR, and VEGF mRNA and protein levels (P<0.05). Compared to the low-dose group of modified Wenyang Sanjie prescription, IFN-γ and IL-2 were increased in the medium-dose and high-dose groups of modified Wenyang Sanjie prescription, while IL-4, IL-6, IL-10, spleen index, thymus index, tumor weight, and tumor microvascular density were decreased, as well as HIF-1α, EGFR, and VEGF mRNA and protein levels (P<0.05). IFN-γ and IL-2 were increased in the high-dose group of modified Wenyang Sanjie prescription compared to the medium-dose group of modified Wenyang Sanjie prescription, and IL-4, IL-6, IL-10, spleen index, thymus index, tumor weight, and tumor microvascular density were decreased, as well as HIF-1α, EGFR, and VEGF mRNA and protein levels (P<0.05). ConclusionModified Wenyang Sanjie prescription can significantly inhibit microangiogenesis, regulate Th1/Th2 balance, inhibit tumor growth, and significantly inhibit the progression of lung cancer in mice.
5.Epidemiological characteristics and trends of non-suicidal self-injury among middle school students in Jiading District of Shanghai from 2015 to 2023
Chinese Journal of School Health 2025;46(9):1282-1286
Objective:
To analyze the epidemiological characteristics and changing trends of non suicidal self injury (NSSI) behaviors among middle school students in Jiading District of Shanghai, from 2015 to 2023, so as to provide a basis for the development of NSSI prevention and control measures among students.
Methods:
Using a stratified cluster random sampling method, a total of five times for Shanghai Adolescent Health Risk Behavior Surveys were conducted for every two years in Jiading District of Shanghai from 2015 to 2023. A total of 5 231 middle school students from junior high schools and senior high schools were selected for questionnaire surveys. Intergroup comparisons were performed using the x 2 test or the χ 2 trend test, and the JointPoint 5.0 software was used to analyze the changing trends, with the annual percent change (APC) used for evaluation. A binary Logistic regression model was employed to analyze the related factors of NSSI behavior among middle school students.
Results:
In 2023, the reported NSSI rate among middle school students in Jiading District was 14.2%. The rate was significantly higher among junior high school students (17.1%) than that among senior high school students (11.1%), and higher among females (19.2%) than that among males (10.0%) ( χ 2=10.04, 23.21, both P <0.01). From 2015 to 2023, the overall reported NSSI rate showed an increasing trend, rising from 8.6% in 2015 to 14.2% in 2023 ( χ 2 trend =22.25), with an APC of 6.64% ( t =3.49), and the APC for girls was 9.79 % ( t =3.20) (all P <0.05). Among students reporting NSSI, the proportion experiencing ≥6 episodes increased from 10.8% in 2015 to 19.2% in 2023 ( χ 2 trend =6.57, P <0.05). Multivariate Logistic regression analysis indicated that girls, junior high school students, those with insomnia, depressive emotion and drinkers had higher risks of NSSI, compared to boys, senior high school students, those without insomnia, non depressive emotion students and non drinkers ( OR =1.71, 1.96, 3.44, 4.76, 1.77, all P < 0.05 ).
Conclusions
The reported rate of NSSI among middle school students in Jiading District of Shanghai, increased annually from 2015 to 2023, and the proportion of repeated NSSI also showed an upward trend. Early intervention measures targeting middle school students, especially junior high school students and females, should be implemented to prevent and control its occurrence and development.
6.Analysis on Acupoint Selection Law for Acupuncture Treatment of Sinusitis Based on Data Mining
Chen LI ; Xinning HU ; Xinxin ZHANG ; Linlin LUO ; Huijun GUO ; Zhicheng ZHANG ; Qianlei XU
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(12):46-52
Objective To analyze the acupoint selection law in acupuncture treatment for sinusitis using data mining techniques.Methods Relevant literature on acupuncture treatment for sinusitis was retrieved from CNKI,Wanfang Data,VIP and CBM from January 1,2000 to December 20,2024.Descriptive statistics were performed on the frequency of acupoint usage,meridian tropism,and regional distribution.SPSS Modeler 18.0,Cytoscape 3.10.3 and Origin Pro were employed to conduct association rule mining,co-occurrence network analysis,and systematic cluster analysis on the acupoints.Results A total of 69 articles were included,yielding 114 acupoint prescriptions involving 65 distinct acupoints.The most frequently used acupoints were Yingxiang,Yintang and Hegu,etc.;the most commonly used meridians were large intestine meridian,Governor Vessel,gallbladder meridian and bladder meridian.Acupoint selection was predominantly concentrated in the head/neck region,lower limbs and upper limbs.Among the specific acupoint categories,Jiaohui acupoint,Wushu acupoint and Yuan acupoint were used most frequently.The acupoint combinations with the strongest associations were Hegu-Yingxiang,Hegu-Yintang-Yingxiang and Fengchi-Yingxiang.The top 22 high-frequency acupoints could be grouped into 5 clusters.Conclusion Acupuncture treatment for sinusitis can exert the functions to disperse wind and unblock the orifices,drain heat and resolve turbidity,expel pathogens and alleviate pain,tonify deficiency and dissipate cold,as well as harmonize qi and blood.The characteristics of acupoint combination include a primary focus on local points supplemented by distal points,pattern differentiation-based selection,and a propensity for unblocking yang qi.The core acupuncture formula is Yingxiang-Yintang-Hegu-Fengchi.
7.Research progress in mechanism of podocyte injury and its potential therapeutic strategies for diabetic nephropathy
Xun LU ; Chengxin MA ; Jianan YANG ; Xinxin GUO ; Xiaobei XIE ; Binghai ZHAO ; Hongzhi LI
Journal of Jilin University(Medicine Edition) 2025;51(5):1415-1422
Diabetic nephropathy(DN)is a significant causative factor of end-stage renal disease globally,and its pathogenesis involves dysregulation of multiple cellular and hormonal pathways.Podocytes play crucial roles in the process of DN,with the extent of podocyte injury closely associated with key pathological manifestations of renal damage,such as proteinuria,glomerular filtration rate,and glomerulosclerosis.However,due to the complexity and interplay of mechanisms contributing to podocyte injury,such as oxidative stress,abnormal lipid metabolism,and mitochondrial damage,the precise mechanisms underlying podocyte injury remain incompletely understood.This review integrated the latest research findings from both domestic and international studies on the core mechanisms of podocyte injury in DN.Furthermore,this article summarized the implications of these mechanisms for DN treatment,particularly focusing on potential therapeutic targets and the development of related pharmacological interventions derived from targeting podocyte injury pathways,so as to provide a theoretical foundation for the development of clinical therapeutic strategies for DN.
8.Erratum: Author correction to "Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury" Acta Pharm Sin B 12 (2022) 1885-1898.
Tengfei XUE ; Juan JI ; Yuqin SUN ; Xinxin HUANG ; Zhenyu CAI ; Jin YANG ; Wei GUO ; Ruobing GUO ; Hong CHENG ; Xiulan SUN
Acta Pharmaceutica Sinica B 2025;15(5):2813-2814
[This corrects the article DOI: 10.1016/j.apsb.2021.10.012.].
9.Intratumoral injection of two dosage forms of paclitaxel nanoparticles combined with photothermal therapy for breast cancer.
Lina SUN ; Cuiling ZUO ; Baonan MA ; Xinxin LIU ; Yifei GUO ; Xiangtao WANG ; Meihua HAN
Chinese Herbal Medicines 2025;17(1):156-165
OBJECTIVE:
In order to enhance the efficacy of anti-breast cancer, paclitaxel nanoparticles (PTX NPs) and polypyrrole nanoparticles (PPy NPs) were combined with photothermal therapy and chemotherapy. At the same time, the two dosage forms of PTX NPs and PTX NPs gel were compared.
METHODS:
PTX NPs were prepared by self-assembly method, and then the cytotoxicity in vitro was investigated by Methyl thiazolyl tetrazolium (MTT) and other methods, and the efficacy and side effects in vivo were further investigated.
RESULTS:
The average hydrated diameter, PDI and electric potential of PTX NPs were (210.20 ± 1.57) nm, (0.081 ± 0.003) mV and (15.80 ± 0.35) mV, respectively. MTT results showed that the IC50 value of PTX NPs on 4 T1 cells was 0.490 μg/mL, while that of PTX injection was 1.737 μg/mL. The cell inhibitory effect of PTX NPs was about 3.5 times higher than that of PTX injection. The tumor inhibition rates of PTX NPs and gel were 48.64% and 56.79%, respectively. Together with local photothermal stimulation, the tumor inhibition rate of the PTX NPs reached 91.05%, surpassing that of the gel under the same conditions (48.98%), moreover, the organ index and H&E staining results of PTX NPs showed a decrease in toxicity.
CONCLUSION
This combination therapy can significantly enhance the effect of anti-breast cancer, and the synergistic effect of chemotherapy and light and heat provides a feasible and effective strategy for the treatment of tumor.
10.Analysis of clinical characteristics and prognostic factors related to ischemic stroke in patients with systemic lupus erythematosus
Lingyao LI ; Xinxin ZHANG ; Le ZHANG ; Ni ZHANG ; Yan GUO ; Yanjie SHI ; Xin LI ; Jing WANG ; Lingfei MO ; Yuanyuan LI ; Hanchao LI ; Xiuyuan FENG
Chinese Journal of Rheumatology 2025;29(9):736-740
Objective:To summarize and analyze the clinical characteristics of systemic lupus erythematosus (SLE) combined with ischaemic stroke and the factors associated with poor prognosis.Methods:A total of 50 patients with SLE combined with ischaemic stroke in the First Affiliated Hospital of Xi′an Jiaotong University from January 2014 to June 2024 were included in the study, the clinical data of the patients were retrospectively collected and summarized, the Shapiro-Wilk test was used to assess the normality of data, and the factors related to poor prognosis were analyzed by logistic regression analyses.Results:Fifty patients with SLE combined with ischaemic stroke had a mean age of (47.1±15.5)years, 80.0%(40/50) were female, the duration of SLE was (5.6±6.3)years, the mean SLEDAI-2K score was (14.3±4.1), the rate of anticardiolipin antibody positivity was 30.0%(15/50), and the rate of β 2-glycoprotein Ⅰ antibody positivity was 28.0%(14/50). The most common clinical manifestations of stroke were impaired limb movement (34.0%) (17/50), cerebral infarction mainly in the cerebral hemisphere (82.0%)(41/50), combined with cerebral haemorrhage in 6.0%(3/50), cerebral leukoencephalopathy in 26.0%(13/50), and cerebral atrophy in 24.0%(12/50). In terms of treatment, the most used immunosuppressant was cyclophosphamide (34.0%, 17/50), 64.0%(32/50) of patients received aspirin, 32.0%(16/50) received clopidogrel and 14.0%(7/50) received anticoagulation. Four deaths and 12 cases of severe disability were found in 50 patients at follow-up, and SLEDAI-2000 scores were positively correlated with the above poor prognosis using univariate [ OR(95% CI)=1.407(1.123,1.764), P=0.003] and multivariate [ OR(95% CI)=1.388(1.097, 1.756), P=0.006] regression analyses. Conclusion:Patients with SLE combined with ischaemic stroke had high disease activity in SLE, and SLEDAI-2000 scores were positively associated with poor prognosis of death and severe disability.


Result Analysis
Print
Save
E-mail